BRIEF-Cell Therapeutics expects to get $67 mln in cash milestone payments from Baxter through 2015 - SEC filing
November 18, 2013 at 06:24 AM EST
Nov 18 (Reuters) - Cell Therapeutics Inc : * Expects could pay up to $96 million in development costs for persist-1 & 2
